The GenMark ePlex ® : Another Weapon in the Syndromic Arsenal for Infection Diagnosis

As one of the most recent additions to the syndromic testing landscape, the ePlex platform by GenMark Diagnostics is a system that combines the manufacturer's signature electrochemical detection technology with updated microfluidics, providing a new option for multiplex testing that is both rap...

Full description

Saved in:
Bibliographic Details
Published inFuture microbiology Vol. 13; no. 16; pp. 1697 - 1708
Main Authors Schmitz, Jonathan E, Tang, Yi-Wei
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.12.2018
Subjects
Clinical trials
Diagnosis
Diagnostic Evaluation
Encephalitis
Infections
Infectious diseases
Laboratories
Manufacturers
Medical diagnosis
Meningitis
Microfluidics
Pathogens
Patients
United States > US
Europe
ePlex
GenMark
respiratory pathogen panel
syndromic infection testing
multiplex molecular testing
Online AccessGet full text

Cover

More Information
Summary:As one of the most recent additions to the syndromic testing landscape, the ePlex platform by GenMark Diagnostics is a system that combines the manufacturer's signature electrochemical detection technology with updated microfluidics, providing a new option for multiplex testing that is both rapid and requires minimal hands-on steps. In this review, we detail the ePlex platform and its current/future syndromic panels, with a particular focus on the respiratory pathogen panel - the platform's first assay to undergo clinical trials and receive regulatory approval in the USA. By keeping informed of these ever-expanding laboratory options, clinicians and microbiologists can stay positioned at the forefront of infectious disease diagnosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1746-0913
1746-0921
1746-0921
DOI:10.2217/fmb-2018-0258